PRFX
Prf Technologies Ltd
NASDAQ · Pharmaceuticals
$2.96
-0.06 (-2.05%)
Open$3.40
Previous Close$3.02
Day High$3.60
Day Low$2.76
52W High$10.99
52W Low$9.40
Volume—
Avg Volume388.9K
Market Cap11.83M
P/E Ratio15.50
EPS$0.66
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+304.1% upside
Current
$2.96
$2.96
Target
$11.96
$11.96
$8.59
$11.96 avg
$16.97
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.33M | 3.45M | 3.63M |
| Net Income | 722.6K | 805.0K | 796.5K |
| Profit Margin | 21.7% | 23.3% | 21.9% |
| EBITDA | 1.33M | 1.25M | 1.35M |
| Free Cash Flow | 449.2K | 396.5K | 453.1K |
| Rev Growth | -7.5% | +9.4% | +15.6% |
| Debt/Equity | 0.57 | 0.65 | 0.63 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |